an intensive regimen of combined etoposide ( vp-16 ) and 5-azacitidine ( 5-az ) was used to treat 96 children and adolescents with refractory or relapsed acute nonlymphocytic leukemia ( anll ) .
C0015133
etoposide
C0023467
acute